Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
about
Structural specializations of α(4)β(7), an integrin that mediates rolling adhesionVedolizumab for inflammatory bowel disease: Changing the game, or more of the same?A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin α4β7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrinsPreliminary in vivo efficacy studies of a recombinant rhesus anti-alpha(4)beta(7) monoclonal antibody.New Data on the Use of Biologic Agents for Crohn's Disease and Ulcerative Colitis: Highlights from the 2009 CCFA Advances in IBD MeetingCD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on alpha4beta7 receptor expression during acute SIV infection.Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system.The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7.A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.Primary follicular lymphoma of the small intestine: alpha4beta7 expression and immunoglobulin configuration suggest an origin from local antigen-experienced B cells.Alpha 4 beta 7 integrin expression is associated with the leukemic evolution of human and murine T-cell lymphoblastic lymphomas.Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes.Expression of the beta 7 integrin by human endothelial cellsIdentification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells.Direct and regulated interaction of integrin alphaEbeta7 with E-cadherin.TLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursorsInterchangeable alpha chain cytoplasmic domains play a positive role in control of cell adhesion mediated by VLA-4, a beta 1 integrin.Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1).Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis.ART influences HIV persistence in the female reproductive tract and cervicovaginal secretions.The unique disulfide bond-stabilized W1 β4-β1 loop in the α4 β-propeller domain regulates integrin α4β7 affinity and signaling.Blocking of α4β7 gut-homing integrin during acute infection leads to decreased plasma and gastrointestinal tissue viral loads in simian immunodeficiency virus-infected rhesus macaquesAdoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus MacaquesDifferential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses.Alpha4(+)beta7(hi)CD4(+) memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection.Optimizing viable leukocyte sampling from the female genital tract for clinical trials: an international multi-site study.Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaquesRare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infectionSurface proteins and glycoproteins of human leucocytes.Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α4β7.Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing.Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.Mutation at a single position in the V2 domain of the HIV-1 envelope protein confers neutralization sensitivity to a highly neutralization-resistant virusIn vitro assessment of the effects of vedolizumab binding on peripheral blood lymphocytesTriggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway.Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
P2860
Q24611768-8160123C-A9BB-4446-93A2-05AD4A2D5D6AQ27021612-C7F25D7A-BA4A-43A4-8FE3-31A4974DE954Q27313287-E33C44A2-0499-4272-A10E-770772AA751CQ30408331-378C258D-F10F-4FB9-9C4B-3A0C89CA8778Q30491140-173B1869-EB9F-424D-A1B9-B52109E79C6DQ33612263-5EBE0BE9-2EB1-46C9-8868-51721EB3B5FBQ33619083-BF4F1F81-307B-42E6-BD57-7D1A83D4F938Q35060140-54C14837-5E63-4BE9-8E0E-8B5984965BEFQ35215649-97EE3AD4-B9DE-472E-B1E7-5CF4F0E47E2EQ35548120-66A8001D-E747-4783-A101-C3D41254BF08Q35748903-B5F8B261-9D0D-42E9-9C54-992EA8C2817DQ35764367-65E598AB-430B-43F2-975E-8204E141FB57Q35765315-3B5993B3-F2B0-4556-BF72-9A9A4DB8F212Q35782426-E6F9191F-492D-4358-AF9F-22E57F922245Q35939722-32C875E6-35D8-4166-8887-EA541D6B949EQ36000722-469052DD-6F3B-4357-AB2B-917304D2E3B5Q36237158-D591350D-65AC-452A-B87A-08DA223810E3Q36254883-AE5AFA72-EC1B-4D86-8F12-19F5CEDD132EQ36349935-AFD31D67-310A-4B65-857F-4ECDC1008CA9Q36362015-CB3759E7-AB4E-415F-BF3A-2E2C105A6132Q36380405-60DE04B4-608E-4E52-8DD9-8731C2750516Q36421628-88FC9110-E939-471B-BDFD-B5CE1F7EAA07Q36618563-2246DBEA-6D48-47FC-B492-B112D73AC363Q36850278-BDB16CF1-F9F3-474C-B79E-44104FBCCA5CQ36952767-53723647-7448-449A-81EE-11DEB9267A22Q37347373-B306B6C5-BCDE-4826-9FEB-49A7ECE758CCQ37365152-9525F88B-F9B5-42A2-8CAA-DEB95EC0F13FQ37390603-3D82E886-B2D9-425E-BF9D-2B96613F78C3Q37484148-DAEABF51-591B-43A0-85B8-790C59C6F1FCQ37547763-8639842D-5F72-4DB2-8A21-ABB5805B1D61Q38849453-42EB4330-F2EA-40A1-849D-B23A9D5FD40AQ39524176-C7C68A29-9ECB-4DE5-856C-DA640B58806EQ40080908-4B78EF1C-BA47-4CDC-8B96-6FC494F95109Q40099506-1C4E35C4-3D47-445E-BE0D-AC0811B7CAD9Q40174150-C38263E1-1D4E-4868-9563-AAC47530B658Q41844960-CC406347-4BA6-49E1-9D49-A94BFA928462Q41880647-C9B1D884-7210-4334-A484-999F79A37A1FQ41899089-E8F7C460-5650-4021-BA5C-1BCFEF7621E6Q41903686-E2B33158-41EF-4EB4-ADCF-4175B2EC0A18Q42840083-E41E84EF-BE0E-4B9D-8AF4-0493D4CFB6B4
P2860
Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
description
1984 nî lūn-bûn
@nan
1984 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@ast
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@en
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@nl
type
label
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@ast
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@en
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@nl
prefLabel
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@ast
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@en
Lymphocyte activation antigens ...... lymphocyte activation antigen.
@nl
P2093
P1476
Lymphocyte activation antigens ...... lymphocyte activation antigen
@en
P2093
Camerini D
Kurnick JT
Lazarovits AI
Moscicki RA
P304
P407
P577
1984-10-01T00:00:00Z